Antibiotic Prevention in Blood Cancer During Chemotherapy
Treatments studied
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests whether giving antibiotics to prevent infections helps patients with myelodysplastic syndromes or acute myeloid leukemia who are starting a specific type of chemotherapy called hypomethylating agents. Preventing infections could help patients stay healthier during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Have a diagnosis of myelodysplastic syndrome, myelodysplastic/myeloproliferative neoplasm, or acute myeloid leukemia
- Be starting hypomethylating agent-based chemotherapy (a type of blood cancer treatment)
- Not have had a fever or infection in the past month
- Not have had a C. difficile infection in the past 12 months
- Be expected to survive at least 30 days based on your doctor's assessment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a targeted antifungal medicine (aimed at PTX3) can better prevent serious fungal infections in adults with AML or a related bone marrow disease who will have very low neutrophils. It may help lower the risk of dangerous infections during intensive chemotherapy hospital stays.
This trial tests if an antibiotic called dalbavancin can help prevent serious bacterial infections in children and young adults with high-risk leukemia whose immune systems are weakened by treatment.
This study looks at certain proteins in the blood (called FLT3 ligand and IL6) of people being treated for blood cancers like AML, MDS, or CMML. The goal is to understand how these proteins change during non-intensive chemotherapy, which may help doctors better personalize treatment.
This trial tests whether using xylitol dental wipes can lower the risk of bloodstream infections in children with acute myeloid leukemia (AML) who are receiving chemotherapy. If you or your child have AML and will have at least two cycles of chemo that include cytarabine, this study may help reduce infection risk.
This Phase 2 study tests whether taking Xerava (an antibiotic) can prevent serious infections in people who have prolonged low neutrophils after chemotherapy or transplant preparation. If it works, it may lower the risk of infections during the highest-risk period after treatment.
This trial compares stopping antibiotics early (after fever resolves) versus continuing them as usual in adults with blood cancers who develop fever during treatment. It aims to find the best timing to reduce unnecessary antibiotic use.
Hear when a new Acute Myeloid Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.